Uppsala, Sweden, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Eurofins Genomics adopts Olink ® technology to advance proteomics research and accelerate precision medicine programs UPPSALA, Sweden, 12 th ...

Investors are always looking for stocks that are poised to beat at earnings season and Olink Holding AB (publ) OLK, may be one such company. The firm has earnings coming up pretty soon, and events are ...

Drug discovery increasingly requires sophisticated analysis of proteins, and Thermo Fisher Scientific is building up its capabilities to support such research with the $3.1 billion acquisition of ...

Ovarian cancer has the highest mortality among gynecological cancers, with surgery often used for final diagnosis. Accurate molecular tests are needed when imaging techniques are inconclusive. We ...

SHANGHAI, Jan. 25, 2022 /PRNewswire/ -- Olink Holding AB (publ) (Nasdaq: OLK) today announced that Sequanta Technologies, a leading multi-omics service provider based in China, will use Olink® Explore ...

Olink’s highly flexible made-to-order product, Olink® Flex, enables you to select and combine targets for up to 21 human proteins in one biomarker panel with results reported in absolute ...

We can readily understand why investors are attracted to unprofitable companies. For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring ...

SPT Labtech and Olink introduced an additional automation option for the Olink ® Explore HT protocol for high-throughput proteomics with SPT Labtech’s firefly ® liquid handling platform. The ...

Olink is a Health Care Tools and Service company focusing on leveraging the new high-growth field of proteomics. Olink just announced a dilutive offering and the share price fell over 16% on the news.

The company posted some impressive anticipated growth figures in a new set of preliminary results. For the former period, the company anticipates its top line will land between $43.2 million and $43.7 ...